Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Iron deficiency anemia associated with extracorporeal photopheresis: A retrospective analysis.

Kuhn AK, Bartoo GT, Dierkhising RA, Mara KC, Winters JL, Patnaik MM, Gastineau DA, Adamski J, Merten JA.

J Clin Apher. 2019 Dec;34(6):666-671. doi: 10.1002/jca.21744. Epub 2019 Aug 22.

PMID:
31436854
2.

Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model.

LeMaistre CF, Wacker KK, Akard LP, Al-Homsi AS, Gastineau DA, Godder K, Lill M, Selby GB, Steinberg A, Anderson JM, Leahigh AK, Warkentin PI.

Biol Blood Marrow Transplant. 2019 Nov;25(11):2243-2250. doi: 10.1016/j.bbmt.2019.06.035. Epub 2019 Jul 5.

PMID:
31284070
3.

The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy.

Mengos AE, Gastineau DA, Gustafson MP.

Front Immunol. 2019 May 22;10:1147. doi: 10.3389/fimmu.2019.01147. eCollection 2019. Review.

4.

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).

Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill JA, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK.

Bone Marrow Transplant. 2019 Nov;54(11):1868-1880. doi: 10.1038/s41409-019-0451-2. Epub 2019 May 15.

PMID:
31092900
5.

The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.

Prokopishyn NL, Logan BR, Kiefer DM, Sees JA, Chitphakdithai P, Ahmed IA, Anderlini PN, Beitinjaneh AM, Bredeson C, Cerny J, Chhabra S, Daly A, Diaz MA, Farhadfar N, Frangoul HA, Ganguly S, Gastineau DA, Gergis U, Hale GA, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Murthy HS, Norkin M, Olsson RF, Papari M, Savani BN, Szer J, Waller EK, Wirk B, Yared JA, Pulsipher MA, Shah NN, Switzer GE, O'Donnell PV, Confer DL, Shaw BE.

Biol Blood Marrow Transplant. 2019 Jul;25(7):1325-1330. doi: 10.1016/j.bbmt.2019.01.034. Epub 2019 Feb 2.

PMID:
30716454
6.

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.

Kansagra AJ, Frey NV, Bar M, Laetsch TW, Carpenter PA, Savani BN, Heslop HE, Bollard CM, Komanduri KV, Gastineau DA, Chabannon C, Perales MA, Hudecek M, Aljurf M, Andritsos L, Barrett JA, Bachanova V, Bonini C, Ghobadi A, Gill SI, Hill J, Kenderian S, Kebriaei P, Nagler A, Maloney D, Liu HD, Shah NN, Kharfan-Dabaja MA, Shpall EJ, Mufti GJ, Johnston L, Jacoby E, Bazarbachi A, DiPersio JF, Pavletic SZ, Porter DL, Grupp SA, Sadelain M, Litzow MR, Mohty M, Hashmi SK.

Biol Blood Marrow Transplant. 2019 Mar;25(3):e76-e85. doi: 10.1016/j.bbmt.2018.12.068. Epub 2018 Dec 18.

PMID:
30576834
7.

Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans.

Wheatley CM, Kannan T, Bornschlegl S, Kim CH, Gastineau DA, Dietz AB, Johnson BD, Gustafson MP.

J Vis Exp. 2018 Oct 17;(140). doi: 10.3791/58417.

PMID:
30394385
8.

Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.

Hefazi M, Langer KJ, Khera N, Adamski J, Roy V, Winters JL, Gastineau DA, Jacob EK, Kreuter JD, Gandhi MJ, Hogan WJ, Litzow MR, Hashmi SK, Yadav H, Iyer VN, Scott JP, Wylam ME, Cartin-Ceba R, Patnaik MM.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1906-1913. doi: 10.1016/j.bbmt.2018.04.012. Epub 2018 Apr 18.

9.

Does matching for SNPs in the MHC gamma block in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant improve outcomes?

Moyer AM, Hashmi SK, Kroning C, De Goey SR, Patnaik M, Litzow M, Gastineau DA, Hogan WJ, Jacob EK, Kreuter JD, Wakefield LL, Gandhi MJ.

Hum Immunol. 2018 Jul;79(7):532-536. doi: 10.1016/j.humimm.2018.04.008. Epub 2018 Apr 13.

PMID:
29660451
10.

Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancer.

Gustafson MP, Bornschlegl S, Park SS, Gastineau DA, Roberts LR, Dietz AB, Hallemeier CL.

Adv Radiat Oncol. 2017 Aug 18;2(4):540-547. doi: 10.1016/j.adro.2017.08.003. eCollection 2017 Oct-Dec.

11.

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma.

Dispenzieri A, D'Souza A, Gertz MA, Laumann K, Wiseman G, Lacy MQ, LaPlant B, Buadi F, Hayman SR, Kumar SK, Dingli D, Hogan WJ, Ansell SM, Gastineau DA, Inwards DJ, Micallef IN, Porrata LF, Johnston PB, Litzow MR, Witzig TE.

Bone Marrow Transplant. 2017 Oct;52(10):1372-1377. doi: 10.1038/bmt.2017.164. Epub 2017 Sep 4.

PMID:
28869617
12.

Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis.

Gustafson MP, Staff NP, Bornschlegl S, Butler GW, Maas ML, Kazamel M, Zubair A, Gastineau DA, Windebank AJ, Dietz AB.

PLoS One. 2017 Jul 25;12(7):e0182002. doi: 10.1371/journal.pone.0182002. eCollection 2017.

13.

Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.

Moyer AM, Hashmi SK, Kroning CM, Kremers WK, De Goey SR, Patnaik M, Litzow M, Gastineau DA, Hogan WJ, Jacob EK, Kreuter JD, Wakefield LL, Gandhi MJ.

Eur J Haematol. 2017 Sep;99(3):275-282. doi: 10.1111/ejh.12916. Epub 2017 Jul 21.

PMID:
28632323
14.

Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy<sup/>.

Barreto JN, McCullough KB, Peskey CS, Dierkhising RA, Mara KC, Elliott MA, Gastineau DA, Al-Kali A, Gangat N, Letendre L, Hogan WJ, Litzow MR, Patnaik MM.

Leuk Lymphoma. 2017 Nov;58(11):2588-2597. doi: 10.1080/10428194.2017.1312384. Epub 2017 May 9.

15.

Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease.

Saad A, Dietz AB, Herrmann SMS, Hickson LJ, Glockner JF, McKusick MA, Misra S, Bjarnason H, Armstrong AS, Gastineau DA, Lerman LO, Textor SC.

J Am Soc Nephrol. 2017 Sep;28(9):2777-2785. doi: 10.1681/ASN.2017020151. Epub 2017 May 1.

16.

A systems biology approach to investigating the influence of exercise and fitness on the composition of leukocytes in peripheral blood.

Gustafson MP, DiCostanzo AC, Wheatley CM, Kim CH, Bornschlegl S, Gastineau DA, Johnson BD, Dietz AB.

J Immunother Cancer. 2017 Apr 18;5:30. doi: 10.1186/s40425-017-0231-8. eCollection 2017.

17.

Autologous stem cell transplant for multiple myeloma patients 70 years or older.

Muchtar E, Dingli D, Kumar S, Buadi FK, Dispenzieri A, Hayman SR, Wolf RC, Gastineau DA, Chakraborty R, Hogan WJ, Leung N, Kapoor P, Lacy MQ, Rajkumar SV, Gertz MA.

Bone Marrow Transplant. 2016 Nov;51(11):1449-1455. doi: 10.1038/bmt.2016.174. Epub 2016 Jul 4.

PMID:
27376447
18.

Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

Hefazi M, Damlaj M, Alkhateeb HB, Partain DK, Patel R, Razonable RR, Gastineau DA, Al-Kali A, Hashmi SK, Hogan WJ, Litzow MR, Patnaik MM.

Transpl Infect Dis. 2016 Dec;18(6):913-920. doi: 10.1111/tid.12612. Epub 2016 Nov 11.

PMID:
27642723
19.

Employment Status as an Indicator of Recovery and Function One Year after Hematopoietic Stem Cell Transplantation.

Morrison EJ, Ehlers SL, Bronars CA, Patten CA, Brockman TA, Cerhan JR, Hogan WJ, Hashmi SK, Gastineau DA.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1690-1695. doi: 10.1016/j.bbmt.2016.05.013. Epub 2016 May 21.

20.

Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic Dosing.

Damlaj M, Alkhateeb HB, Hefazi M, Partain DK, Hashmi S, Gastineau DA, Al-Kali A, Wolf RC, Gangat N, Litzow MR, Hogan WJ, Patnaik MM.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1431-1439. doi: 10.1016/j.bbmt.2016.04.026. Epub 2016 May 7.

21.

Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma.

Porrata LF, Burgstaler EA, Winters JL, Jacob EK, Gastineau DA, Suman VJ, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Nevala W, Markovic SN.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1017-1023. doi: 10.1016/j.bbmt.2016.01.024. Epub 2016 Jan 27.

22.

The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation.

Leung N, Kumar SK, Glavey SV, Dispenzieri A, Lacy MQ, Buadi FK, Hayman SR, Dingli D, Kapoor P, Zeldenrust SR, Russell SJ, Lust JA, Hogan WJ, Rajkumar SV, Gastineau DA, Kourelis TV, Lin Y, Gonsalves WI, Go RS, Gertz MA.

Nephrol Dial Transplant. 2016 Aug;31(8):1284-9. doi: 10.1093/ndt/gfv328. Epub 2015 Nov 30.

PMID:
26627634
23.

Immune independent crosstalk between lymphoma and myeloid suppressor CD14+HLA-DRlow/neg monocytes mediates chemotherapy resistance.

Zhang ZJ, Bulur PA, Dogan A, Gastineau DA, Dietz AB, Lin Y.

Oncoimmunology. 2015 Jan 26;4(4):e996470. eCollection 2015 Apr.

24.

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma.

Gustafson MP, Lin Y, Bleeker JS, Warad D, Tollefson MK, Crispen PL, Bulur PA, Harrington SM, Laborde RR, Gastineau DA, Leibovich BC, Cheville JC, Kwon ED, Dietz AB.

Clin Cancer Res. 2015 Sep 15;21(18):4224-33. doi: 10.1158/1078-0432.CCR-15-0260. Epub 2015 May 21.

25.

A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans.

Gustafson MP, Lin Y, Maas ML, Van Keulen VP, Johnston PB, Peikert T, Gastineau DA, Dietz AB.

PLoS One. 2015 Mar 23;10(3):e0121546. doi: 10.1371/journal.pone.0121546. eCollection 2015.

26.

Disseminated intravascular coagulation: a bigger problem as cancer therapy improves.

Gastineau DA.

Oncology (Williston Park). 2015 Feb;29(2):102-3. No abstract available.

27.

Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.

Mulay S, Kreuter JD, Bryant SC, Elliott MA, Hogan WJ, Winters JL, Gastineau DA.

J Clin Apher. 2015 Jun;30(3):147-53. doi: 10.1002/jca.21352. Epub 2014 Sep 17.

PMID:
25230249
28.

Self-regulatory fatigue, quality of life, health behaviors, and coping in patients with hematologic malignancies.

Solberg Nes L, Ehlers SL, Patten CA, Gastineau DA.

Ann Behav Med. 2014 Dec;48(3):411-23. doi: 10.1007/s12160-014-9621-z.

29.

Infusion technique of hematopoietic progenitor cells and related adverse events (CME).

Mulay SB, Greiner CW, Mohr A, Bryant SC, Lingineni RK, Padley D, Hogan WJ, Gastineau DA, Jacob EK.

Transfusion. 2014 Aug;54(8):1997-2003; quiz 1996. doi: 10.1111/trf.12572. Epub 2014 Feb 17.

PMID:
24697759
30.

The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).

Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA.

BJU Int. 2014 Sep;114(3):368-74. doi: 10.1111/bju.12535. Epub 2014 Jan 29.

31.

Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.

Kumar SK, Mikhael J, Laplant B, Lacy MQ, Buadi FK, Dingli D, Gertz MA, Laumann K, Miceli T, Mahlman M, Bergsagel LP, Hayman SR, Reeder C, Stewart AK, Dispenzieri A, Gastineau DA, Winters JL.

Bone Marrow Transplant. 2014 Feb;49(2):201-5. doi: 10.1038/bmt.2013.175. Epub 2013 Nov 4.

32.

Long-term outcome of patients with multiple [corrected] myeloma-related advanced renal failure following auto-SCT.

Glavey SV, Gertz MA, Dispenzieri A, Kumar S, Buadi F, Lacy M, Hayman SR, Kapoor P, Dingli D, McCurdy A, Hogan WJ, Gastineau DA, Leung N.

Bone Marrow Transplant. 2013 Nov;48(12):1543-7. doi: 10.1038/bmt.2013.109. Epub 2013 Aug 5. Erratum in: Bone Marrow Transplant. 2014 Jul;49(7):996. Kapoor, P [added].

PMID:
23912663
33.

Discordant CD34+ cell results in peripheral blood and hematopoietic progenitor cell-apheresis product: implications for clinical decisions and impact on patient treatment.

Liwski CJ, Padley DJ, Gustafson MP, Winters JL, Gastineau DA, Jacob EK.

Transfusion. 2014 Mar;54(3):541-4. doi: 10.1111/trf.12324. Epub 2013 Jun 30.

PMID:
23808629
34.

Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation.

Singla A, Hogan WJ, Ansell SM, Buadi FK, Dingli D, Dispenzieri A, Gastineau DA, Gertz MA, Hayman SR, Inwards DJ, Johnston PB, Lacy MQ, Litzow MR, Micallef IN, Porrata LF, Kumar SK.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1233-7. doi: 10.1016/j.bbmt.2013.05.019. Epub 2013 Jun 6.

35.

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.

Dispenzieri A, Seenithamby K, Lacy MQ, Kumar SK, Buadi FK, Hayman SR, Dingli D, Litzow MR, Gastineau DA, Inwards DJ, Micallef IN, Ansell SM, Johnston PB, Porrata LF, Patnaik MM, Hogan WJ, Gertz MA.

Bone Marrow Transplant. 2013 Oct;48(10):1302-7. doi: 10.1038/bmt.2013.53. Epub 2013 Apr 22. Review.

PMID:
23604010
36.

Immune monitoring using the predictive power of immune profiles.

Gustafson MP, Lin Y, LaPlant B, Liwski CJ, Maas ML, League SC, Bauer PR, Abraham RS, Tollefson MK, Kwon ED, Gastineau DA, Dietz AB.

J Immunother Cancer. 2013 Jun 27;1:7. doi: 10.1186/2051-1426-1-7. eCollection 2013.

37.

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

Larsen JT, Hogan WJ, Micallef IN, Dispenzieri A, Gertz MA, Inwards DJ, Tun HW, Roy V, Geyer SM, Allred JB, Wu W, Ansell SM, Elliott MA, Tefferi A, Porrata LF, Gastineau DA, Lacy MQ, Litzow MR.

Leuk Lymphoma. 2013 Aug;54(8):1713-8. doi: 10.3109/10428194.2012.753444. Epub 2012 Dec 31.

PMID:
23189958
38.

Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization.

Micallef IN, Sinha S, Gastineau DA, Wolf R, Inwards DJ, Gertz MA, Hayman SR, Hogan WJ, Johnston PB, Lacy MQ, Ansell SM, Buadi F, Dingli D, Dispenzieri A, Litzow MR, Porrata LF, Winters JL, Kumar S.

Biol Blood Marrow Transplant. 2013 Jan;19(1):87-93. doi: 10.1016/j.bbmt.2012.08.010. Epub 2012 Aug 23.

39.

Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis.

Irazabal MV, Eirin A, Gertz MA, Dispenzieri A, Kumar S, Buadi FK, Lacy MQ, Hayman SR, Dingli D, Hogan WJ, Gastineau DA, Glavey SV, Amer H, Leung N.

Am J Hematol. 2012 Jan;87(1):51-4. doi: 10.1002/ajh.22202. Epub 2011 Nov 11.

40.

Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL).

Gustafson MP, Abraham RS, Lin Y, Wu W, Gastineau DA, Zent CS, Dietz AB.

Br J Haematol. 2012 Mar;156(5):674-6. doi: 10.1111/j.1365-2141.2011.08902.x. Epub 2011 Nov 3. No abstract available.

41.

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies.

Sinha S, Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, Dingli D, Micallef IN, Hogan WJ, Gastineau DA, Rajkumar SV, Kumar SK.

Leukemia. 2012 May;26(5):1119-22. doi: 10.1038/leu.2011.308. Epub 2011 Oct 28. No abstract available.

PMID:
22033494
42.

Cancer-related TTP and considerations of plasma exchange.

Gastineau DA.

Oncology (Williston Park). 2011 Sep;25(10):924, 926. No abstract available.

43.

Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma.

Ozsan GH, Micallef IN, Dispenzieri A, Kumar S, Lacy MQ, Dingli D, Hayman SR, Buadi FK, Wolf RC, Gastineau DA, Hogan WJ, Gertz MA.

Am J Hematol. 2012 Jan;87(1):1-4. doi: 10.1002/ajh.22179. Epub 2011 Sep 29.

44.

Self-regulatory fatigue in hematologic malignancies: impact on quality of life, coping, and adherence to medical recommendations.

Solberg Nes L, Ehlers SL, Patten CA, Gastineau DA.

Int J Behav Med. 2013 Mar;20(1):13-21. doi: 10.1007/s12529-011-9194-1.

45.

Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models.

Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, Eberhardt NL, Kudva YC.

Lab Anim. 2011 Jul;45(3):131-40. doi: 10.1258/la.2010.010090. Epub 2011 Apr 8. Review.

46.

Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.

Lin Y, Gustafson MP, Bulur PA, Gastineau DA, Witzig TE, Dietz AB.

Blood. 2011 Jan 20;117(3):872-81. doi: 10.1182/blood-2010-05-283820. Epub 2010 Nov 9.

47.

SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization.

Gertz MA, Gastineau DA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Dingli D, Leung N, Wolf RC, Hogan WJ, Buadi FK.

Bone Marrow Transplant. 2011 Jul;46(7):956-61. doi: 10.1038/bmt.2010.233. Epub 2010 Oct 25.

PMID:
20972466
48.

Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report.

Gertz MA, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Dingli D, Ansell SM, Gastineau DA, Inwards DJ, Johnston PB, Litzow MR, Micallef IN, Porrata LF, Leung N, Hogan WJ, Buadi FK.

Leuk Lymphoma. 2010 Dec;51(12):2181-7. doi: 10.3109/10428194.2010.524329. Epub 2010 Oct 20.

PMID:
20958232
49.

A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

Dispenzieri A, Wiseman GA, Lacy MQ, Hayman SR, Kumar SK, Buadi F, Dingli D, Laumann KM, Allred J, Geyer SM, Litzow MR, Gastineau DA, Inwards DJ, Micallef IN, Ansell SM, Porrata L, Elliott MA, Johnston PB, Hogan WJ, Gertz MA.

Am J Hematol. 2010 Jun;85(6):409-13. doi: 10.1002/ajh.21696.

50.

The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia.

Ehlers SL, Gastineau DA, Patten CA, Decker PA, Rausch SM, Cerhan JR, Hogan WJ, Ebbert JO, Porrata LF.

Bone Marrow Transplant. 2011 Feb;46(2):285-90. doi: 10.1038/bmt.2010.113. Epub 2010 May 17.

Supplemental Content

Loading ...
Support Center